“I know nothing in the world that has as much power as a word…” Emily Dickinson
Writing quality copy is a specialised craft. We are passionate about developing accurate, evidence-based materials that achieve the strategic objective, whilst satisfying the needs of the audience. We produce concise, compelling, code-compliant materials, minimising hassle and frustration associated with copy approval. We have extensive knowledge and experience across a broad range of therapeutic areas and mediums, providing timely, cost-effective, high quality medical communications.
- Anaesthesia
- Anti-infectives
- Cardiology
- CNS
- Consumer medicines
- Diabetes
- Epilepsy
- Fertility
- Gastroenterology
- Haematology
- Hepatitis
- Herpes
- HIV medicine
- Multiple sclerosis
- Nephrology
- Oncology
- Pain management
- Parkinson’s disease
- Rare diseases
- Respiratory medicine
- Rheumatology
- Transplantation
- Urology
- Vaccines
- Virology
| Medical Education |
|---|
- Slide decks
- Conference reports
- Newsletters, bulletins
- Treatment guidelines
- Product monographs
- Consensus statements
- Editorials, advertorials
- Clinical summaries
- Continuing Medical Education (CME)
- Compliance review
| Advisory Board/Meetings |
|---|
- Advisory board proceedings
- Scientific symposium highlights, bulletins, communications
| Promotional Material |
|---|
- Speaker slide kits
- Sales/detail aids
- Leave behinds
- Mailers
- Website content
- Compliance review
| Scientific Manuscripts |
|---|
- Manuscripts for publication
- Scientific abstracts
- Scientific posters
Our rigorous processes ensure a high quality result:
1. Objective
Before beginning any project we work with you to fully understand your strategic imperative, target audience and specific needs. We offer creative suggestions, anticipate potential roadblocks and provide cost-effective solutions. This rigorous process ensures a high quality result.
2. Scope
We take the time to develop a comprehensive written proposal with clear project objectives, audience needs, deliverables and fully-itemised costs.
3. Develop
We communicate regularly throughout the project with key stakeholders. In alignment with the written proposal, we create quality, evidence-based materials that meet high compliance standards, whilst ensuring the strategic objective is met.
4. Deliver
We deliver projects on time and on budget, in accordance with the written proposal. Any deviations or waivers from the written proposal are discussed and agreed in advance.
5. Assess
We regularly seek feedback and continuously assess, refine and seek process improvements or innovations.
6. Results
We have a proven track record for producing concise, consistently high quality medical communications that achieve business results.
Bioscript have written manuscripts for publication in respected medical journals including:
- Bleasel K, Heddle R, Hissaria P, et al. Pharmacokinetics and safety of Intragam 10 NF, the next generation 10% liquid intravenous immunoglobulin, in patients with primary antibody deficiencies. Internal Medical Journal 2012;42(3):252-9.
- Jose MD, Johnson DW, Mudge DW, et al. Peritoneal dialysis practice in Australia and New Zealand: A call to action. Nephrology 2011;16(1):19-29.
- hong B, Gang E, Bird R, et al. An open-label, multicentre study evaluating the efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with primary immune thrombocytopenia (ITP). Asia-Pacific Journal of Oncology and Hematology 2010;2(2):7-12.
- Bilton D, Daviskas E, Anderson SD, et al. A phase III randomised study of the efficacy and safety of inhaled dry powder mannitol (Bronchitol) for the symptomatic treatment of non-cystic fibrosis bronchiectasis. A randomised, placebo-controlled, double-blind study to assess the efficacy and safety of mannitol twice daily in bronchiectasis subjects. Chest 2013;144(1):215-25.